Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01090154 · ClinicalTrials.gov registry record · Phase 2
Study of Cimzia for the Treatment of Ulcerative Colitis
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT01090154 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 27 participants.
The verdict
NCT01090154, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Cimzia (certolizumab pegol) is an effective treatment for patients with Ulcerative colitis.
Interventions
- DRUG Cimzia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2010-12-01 |
| Est. Completion | 2021-12-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01090154
The ClinicalTrials.gov registry entry for NCT01090154 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cimzia is the first listed.
NCT01090154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01090154 about?
NCT01090154 is a clinical study titled "Study of Cimzia for the Treatment of Ulcerative Colitis". The purpose of this study is to determine if Cimzia (certolizumab pegol) is an effective treatment for patients with Ulcerative colitis.
What is the current status of trial NCT01090154?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2010-12-01. Estimated completion is 2021-12-10.
What interventions are being tested in trial NCT01090154?
The interventions under investigation include: Cimzia (DRUG).
Who is sponsoring clinical trial NCT01090154?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.